According to Pfizer, its 3-dose COVID-19 vaccine showed a strong immune response in children under the age of 5

For the latest news and information on the coronavirus pandemic, visit the WHO and CDC websites.

Pfizer and BioNTech’s three doses COVID-19 Vaccine for children aged six months to under five years generated a strong immune response, the companies said on Monday.

That Vaccination for younger children has an effectiveness of just over 80% according to a preliminary analysis. The findings are based on clinical trials in which children received 3 microgram doses — one-tenth the adult dose — of the COVID-19 vaccine. After a third dose, the companies said the vaccine elicited a strong immune response with only mild to moderate side effects.

“The study suggests that a low 3 µg dose of our vaccine, carefully selected based on safety data, provides high protection against the new COVID-19 strains in young children,” said Dr. Ugur Sahin, CEO and co-founder of BioNTech, in a press release. “We are preparing the relevant documents and expect to complete the submission process to the FDA this week, with filings to the EMA and other regulators to follow in the coming weeks.”

While the US Centers for Disease Control and Prevention signed an agreement last week Booster dose of COVID-19 vaccine for children aged 5 to 11 yearsParents have been waiting for a vaccine to be approved for this younger age group.

Pfizer originally transmitted data to the Food and Drug Administration in February for emergency use approval of its vaccine for babies, toddlers and children under 5, but postponed the official application and authorization process to await additional data on a third dose. Moderna and Pfizer have both asked the FDA to approve low-dose vaccines for the youngest age group, and the agency has a tentative timeline in June to review data on both companies’ vaccines.

Last week, the US passed the bleak milestone of 1 million deaths from COVID-19, and cases and hospitalization rates have risen across the country. Responsible are new, more contagious versions of the Omicron variant. While the numbers are lower than last winter’s surge, the surge threatens the easing of some safety measures, such as B. Mandates to take off masks.

The information contained in this article is for educational and informational purposes only and is not intended as health or medical advice. Always consult a physician or other qualified healthcare provider with any questions about a medical condition or health goals. According to Pfizer, its 3-dose COVID-19 vaccine showed a strong immune response in children under the age of 5

Chris Barrese

InternetCloning is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Back to top button